Board of Directors

Board of Directors

Gun-Britt Fransson, chairman of the board since 2018

Gun-Britt Fransson has more than 30 years of experience in management, business development and R&D in biotechnology as well as food and pharmaceutical development. Until 2018, Fransson worked as VP R & D at Probi AB. She has also been CEO of Alligator Bioscience AB and research director at Orkla Foods A / S and held research-leading positions within KabiPharmacia AB. Fransson has extensive experience of board work and has been chairman and board member of both private and public companies, foundations and universities.


Shares in the company:
Gun-Britt Fransson owns 53,333 shares in Follicum

Other significant ongoing assignments:

  • Invent Medic Sweden AB: Chairman of the Board
  • Medimi AB: Board Member
  • Partner in Lighthouse HB: Board Member
  • Lighthouse Life Science Consulting AB: Deputy Board Member

Alejandra Mørk, member of the board since 2018

Alejandra Mørk is the CEO of KLIFO. Previously, she worked for Nycomed Pharma for 18 years, in various senior positions in drug development and “life cycle management”. Alejandra is a board member of Dansk Biotech and a member of the Danish Academy of Engineering Sciences. She is also a member of the EUCROF Pediatric Working Group.


Shares in the company:
Alejandra Mørk does not own, privately or through companies, any shares in Follicum

Other significant ongoing assignments:

  • Cyxone AB: Board Member
  • Heron Holding AS: Board Member

Lars H. Bruzelius, member of the board since 2013

Lars H. Bruzelius is an associate professor of business administration and management consultant with extensive experience from several industries, including medical technology. Among other things, he has has been CEO and administrative director of Gambro AB and started, developed and owned and been CEO of management consulting companies. In recent years, Bruzelius has worked as a board member in various companies and invested in a number of start-up companies, primarily in life science.


Shares in the company:
Lars Bruzelius owns 2,798,047 shares in Follicum via Brushamn Invest Aktiebolag

Other significant ongoing assignments:

  • Brushamn Holding Aktiebolag: Board Member
  • Brushamn Invest Aktiebolag: Board Member
  • Lund University Scholarship Foundation: Board Member

Carl-Johan Spak, member of the board since 2019

Carl-Johan Spak is Senior Advisor at Flerie Invest. Between 2009 and 2020, he was active in leading positions within Recipharm, most recently as CEO of Recipharm Venture Fund AB. He has over 30 years of experience from the pharmaceutical industry in roles as CEO of both small start-ups and larger pharmaceutical companies. Carl-Johan is a dentist and doctor of dentistry.

Carl-Johan Spak, Member of the Board, Follicum

Shares in the company:
No shares.

Other significant ongoing assignments:

  • Pharmacolog i Uppsala AB, Board Member
  • Symcel Sverige AB, Board Member
  • Empros Pharma AB, Board Member
  • Atrogi AB, Board Member
  • Prokarium Ltd, Board Member
  • Prokarium Holdings Ltd, Board Member
  • Kahr Medical Ltd, Board Member
  • EpiEndo ehf, Board Member
  • Xspray AB, Board Member
  • Buzzard Pharmaceuticals AB, Deputy Board Member